Market Access Matters Access Infinity

In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma organisations. Becky joined Sanofi this year as HEVA, Neurology and Immunology Team Leader and explains the key priorities for HEOR teams and their role in working closely with market access to help them define and communicate patient value.The discussion also explores the role of AI for HEOR and market access teams&nbs...

Adrian Harrington, Senior Director Value and Access at Biogen, joins the podcast to discuss market access excellence – what it means to him, and the critical role visual communication is playing for market access leaders.Adrian also shares his views on what’s next for the market access function, detailing why leaders must embrace opportunities to demonstrate the value of market access and tell the story of their team’s success.Strong communication strategies are clearly important to Adrian an...

In this special episode, Louise teams up with colleagues Thomas Gilboy and Shravani Madishetti from Access Infinity to explore the transformative impact of digital on market access. Shravani, APAC Pricing and Market Access Lead, highlights the efficiency and accuracy achieved through digital tools while Tom, Product Owner for Nuro, emphasises the importance of maximising the effectiveness of digital tools. Together, they offer valuable insights and practical guidance for navigating this evolv...

In the third episode of series 2, Louise interviews Khalid Mirza, Senior Director, Global Market Access & Pricing, Oncology at Daiichi Sankyo. They discuss Khalid's journey into market access, and how, for him, it's evolved into an exciting career path where science meets commercial.They also touch on the key themes shaping the future of market access, where Khalid's positive energy and passion for the function shines. The opinions shared in this episode are Khalid's own ...

In this episode Louise teams up with Access Infinity Partner, Nick Proctor. Nick has been a consultant in the biopharmaceutical industry for over twenty years and shares his views on the hot topics and trends which he feels will have the biggest impact on market access in the coming years, also offering his insights on the themes which are 'hype'. Throughout his career Nick has also been responsible for training, coaching and mentoring others in global market access and pricing, and talk...

Welcome back to the Market Access Matters podcast! In the first episode of series 2, Louise interviews David McConkey, Virology and Oncology Global Value and Access Director at Gilead Services. Having started his career in consulting and then working across global and country roles, David has a breadth of experience in market access. In this discussion he shares his experiences of taking on new challenges, leading teams into new territories and what he's learnt along the way. ...